ArticleFrontiers in immunology2021

Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR Clonotypes.

Hussein A Abbas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.